Cancer is the second leading cause of death worldwide. Toward the end of life, individuals with cancer experience a substantial symptom burden. The top three common symptoms in patients with cancer at the end of life are fatigue, pain, and anorexia (appetite loss). Anorexia is a component of the cancer
anorexia-cachexia syndrome (CACS). It is the lack or loss of appetite or desire to eat leading to reduced intake of food.
&nbsp;
Cancer Anorexia Epidemiological Segmentation&nbsp;
&nbsp;
<ul>
<li>Total Incidence Cases of Anorexia by Cancer Types&nbsp;</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #0047b2;" href="https://www.delveinsight.com/report-store/cancer-anorexia-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Cancer Anorexia Epidemiological Insights</a> Observed in 2020
&nbsp;
<ul>
<li>The total incident cases of cancer-related Anorexia in 7MM were found to be 740,055.</li>
<li>The incidence population of Anorexia by cancer types in the United States was observed to be 265,539.</li>
<li>The Cancer Anorexia cases in EU5 countries were found to be 276,713.</li>
<li>Among EU5 countries, the number of incident cancer cases by type in Germany was found to be 72,040, whereas, in Spain, there were 36,474 cases.</li>
<li>The number of incident cases of Cancer Anorexia in Japan was observed to be 197,803.</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/cancer-anorexia-market" target="_blank" rel="noopener noreferrer">Cancer Anorexia Market Insight</a>
&nbsp;
The market size of Cancer Anorexia in the 7MM was found to be USD 313.52 million in 2020.&nbsp;
&nbsp;
Cancer Anorexia Market Drivers
&nbsp;
<ul>
<li>The increasing population of cancer patients with Anorexia</li>
<li>Scope of upcoming therapies</li>
<li>Opportunity for novel treatments</li>
<li>Presence of an effective disease scoring system</li>
</ul>
&nbsp;
Cancer Anorexia Market Barriers
&nbsp;
<ul>
<li>Disease burden and impact on quality of life</li>
<li>Lack of disease understanding</li>
<li>High mortality rate in cancer patients due to Anorexia</li>
</ul>
&nbsp;
Cancer Anorexia Emerging Drugs
&nbsp;
The emerging drugs of the Cancer Anorexia market are
&nbsp;
<ul>
<li>Adlumiz/Edolmizu</li>
<li>ART27.13</li>
<li>NGM120, and others</li>
</ul>
&nbsp;
Cancer Anorexias Key Players
&nbsp;
The key players working in the Cancer Anorexia market are
&nbsp;
<ul>
<li>Helsinn Healthcare</li>
<li>Artelo Biosciences</li>
<li>NGM Biopharmaceuticals, and others</li>
</ul>
&nbsp;
Stay tuned for recent updates on <a style="background-color: transparent; color: #0047b2;" href="https://www.delveinsight.com/whitepaper-newsletter/cancer-anorexia-market" target="_blank" rel="noopener noreferrer">Cancer Anorexia Treatment Landscape</a>

Cancer Anorexia Market

Cancer Anorexia symptoms, treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape